There is no correlation between the platelet count and risk of thrombosis, but some patients with extreme thrombocytosis (ie, > 1, 000, 000 / mcL [> 1000 × 10 9 / L]) develop bleeding due to loss of high molecular weight von Willebrand factor multimers (acquired type 2B von Willebrand disease).